Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival

BMC Medical Genomics

Volumn 4, Issue , 2011, Pages

  Serão, Nicola Vl ^a   Delfino, Kristin R ^a   Southey, Bruce R ^a   Beever, Jonathan E ^a   Rodriguez Zas, Sandra L ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; AKR1C3 GENE; APOOL GENE; APOPTOSIS; ARTICLE; C2 GENE; CAMK2G GENE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL CYCLE; CHEMORADIOTHERAPY; CHI3L1 GENE; COHORT ANALYSIS; CSF1 GENE; E2F3 GENE; EGFR GENE; FEMALE; FSTL1 GENE; GDF10 GENE; GENDER; GENE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GLIOBLASTOMA; HRAS GENE; HUMAN; IGF2BP3 GENE; IGHG1 GENE; II13RA1 GENE; JAG2 GENE; MAJOR CLINICAL STUDY; MALE; MDM2 GENE; MORPHOGENESIS; MTAP GENE; OVERALL SURVIVAL; PAICS GENE; PDCD4 GENE; PIK3R1 GENE; PLA2G7 GENE; PLCG1 GENE; POLR2D GENE; PRIORITY JOURNAL; PRKCB GENE; PROGNOSIS; PROGRESSION FREE SURVIVAL; RAB31 GENE; RACE; RPL37A GENE; RPS20 GENE; SOD2 GENE; SOX10 GENE; STIMULUS RESPONSE; SYNE1 GENE; TGFA GENE; TOPORS GENE; TP53 GENE; VAV3 GENE; ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; CHEMISTRY; DISEASE COURSE; DISEASE FREE SURVIVAL; DNA PROBE; ENZYMOLOGY; GENE REGULATORY NETWORK; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; REPRODUCIBILITY; SURVIVAL; TUMOR GENE;

PROTEIN KINASE C; PROTEIN KINASE C BETA; SPECTRIN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; CELL CYCLE; COHORT STUDIES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DNA PROBES; FEMALE; GENE REGULATORY NETWORKS; GENES, NEOPLASM; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; MORPHOGENESIS; PROPORTIONAL HAZARDS MODELS; PROTEIN KINASE C; REPETITIVE SEQUENCES, AMINO ACID; REPRODUCIBILITY OF RESULTS; SPECTRIN; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79957967092     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-4-49     Document Type: Article

References (131)

1. Astrocyte Differentiation States and Glioma Formation. C Dai E Holland, Glioblastoma Multiforme Jones and Barlett Publishers, Markert J,DeVita Jr VT,Rosenberg SA,Hellman S.Sudbury, MA, 1 2005 1
2. Genetic pathways to glioblastoma: a population-based study. H Ohgaki P Dessen B Jourde S Horstmann T Nishikawa PL Di Patre C Burkhard D Schuler NM Probst-Hensch PC Maiorka N Baeza P Pisani Y Yonekawa MG Yasargil UM Lutolf P Kleihues, Cancer (Pubitemid 39330996)
3. MicroRNA involvement in glioblastoma pathogenesis. J Novakova O Slaby R Vyzula J Michalek, Biochem Biophys Res Commun 2009 386 1 1 5 10.1016/j.bbrc.2009.06.034 19523920
4. Epidemiology of primary brain tumors: current concepts and review of the literature. M Wrensch Y Minn T Chew M Bondy MS Berger, Neuro Oncol 2002 4 4 278 299 12356358
5. Adult High-Grade Glioma. N Butowski S Chang, High-Grade Gliomas Diagnosis and Treatment Humana Press, Barnett GH. Danvers, MA, 1 2006 59
6. Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults. S Kesari D Schiff JW Henson A Muzikansky DC Gigas L Doherty TT Batchelor JA Longtine KL Ligon S Weaver A Laforme N Ramakrishna PM Black J Drappatz A Ciampa J Folkman M Kieran PY Wen, Neuro Oncol 2008 10 3 300 308 10.1215/15228517-2008-005 18403492
7. Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. MJ McGirt KD Than JD Weingart KL Chaichana FJ Attenello A Olivi J Laterra LR Kleinberg SA Grossman H Brem A Quinones-Hinojosa, J Neurosurg 2009 110 3 583 588 10.3171/2008.5.17557 19046047
8. Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents. G Minniti R Muni G Lanzetta P Marchetti RM Enrici, Anticancer Res 2009 29 12 5171 5184 20044633
9. Rationale for carbon ion therapy in high-grade glioma based on a review and a meta-analysis of neutron beam trials. D Maucort-Boulch MH Baron P Pommier DC Weber JE Mizoe J Rochat JP Boissel J Balosso H Tsujii E Amsallem, Cancer Radiother 2010 14 1 34 41 20004126
10. Identification of molecular subtypes of glioblastoma by gene expression profiling. PS Mischel R Shai T Shi S Horvath KV Lu G Choe D Seligson TJ Kremen A Palotie LM Liau TF Cloughesy SF Nelson, Oncogene 2003 22 15 2361 2373 10.1038/sj.onc.1206344 12700671 (Pubitemid 36566791)
11. Gene expression profiling and genetic markers in glioblastoma survival. JN Rich C Hans B Jones ES Iversen RE McLendon BK Rasheed A Dobra HK Dressman DD Bigner JR Nevins M West, Cancer Res 2005 65 10 4051 4058 10.1158/0008-5472.CAN- 04-3936 15899794 (Pubitemid 40775641)
12. Prognostic impact of molecular markers in a series of 220 primary glioblastomas. C Houillier J Lejeune A Benouaich-Amiel F Laigle-Donadey E Criniere K Mokhtari J Thillet JY Delattre K Hoang-Xuan M Sanson, Cancer 2006 106 10 2218 2223 10.1002/cncr.21819 16568472 (Pubitemid 43673244)
13. Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation. L Wang Q Wei LE Wang KD Aldape Y Cao MF Okcu KR Hess R El-Zein MR Gilbert SY Woo SS Prabhu GN Fuller ML Bondy, J Clin Oncol 2006 24 10 1627 1632 10.1200/JCO.2005.04.0402 16575014 (Pubitemid 46638787)
14. Long-term survival with glioblastoma multiforme. D Krex B Klink C Hartmann A von Deimling T Pietsch M Simon M Sabel JP Steinbach O Heese G Reifenberger M Weller G Schackert German Glioma Network, Brain 2007 130 Pt 10 2596 2606 17785346 (Pubitemid 47511715)
15. Meta-analysis of glioblastoma multiforme versus anaplastic astrocytoma identifies robust gene markers. JM Dreyfuss MD Johnson PJ Park, Mol Cancer 2009 8 71 10.1186/1476-4598-8-71 19732454
16. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. B Gyorffy A Lanczky AC Eklund C Denkert J Budczies Q Li Z Szallasi, Breast Cancer Res Treat 2009
17. Gene expression analysis of an EGFR indirectly related pathway identified PTEN and MMP9 as reliable diagnostic markers for human glial tumor specimens. S Comincini M Paolillo G Barbieri S Palumbo E Sbalchiero A Azzalin MA Russo S Schinelli, J Biomed Biotechnol 2009 2009 924565 19657395
18. Development of a predictor for human brain tumors based on gene expression values obtained from two types of microarray technologies. X Castells JJ Acebes S Boluda A Moreno-Torres J Pujol M Julia-Sape AP Candiota J Arino A Barcelo C Arus, OMICS 2010 14 2 157 164 10.1089/omi.2009.0093 20235875
19. Evaluation of the prognostic value of CD44 in glioblastoma multiforme. KC Wei CY Huang PY Chen LY Feng TW Wu SM Chen HC Tsai YJ Lu NM Tsang CK Tseng PC Pai JW Shin, Anticancer Res 2010 30 1 253 259 20150644
20. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Cancer Genome Atlas Research Network, Nature 2008 455 7216 1061 1068 10.1038/nature07385 18772890
21. TCGA Data Portal. http://tcga-data.nci.nih.gov/tcga/tcgaHome2.jsp
22. Methods for Affymetrix Oligonucleotide Arrays. RA Irizarry L Gautier BM Bolstad C Miller, http://bioconductor.org/packages/2.5/bioc/html/affy.html
23. Beehive. http://stagbeetle.animal.uiuc.edu/Beehive
24. Genomic expression patterns distinguish long-term from short-term glioblastoma survivors: a preliminary feasibility study. NF Marko SA Toms GH Barnett R Weil, Genomics 2008 91 5 395 406 10.1016/j.ygeno.2008.01.002 18343632
25. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis. SP Reddy R Britto K Vinnakota H Aparna HK Sreepathi B Thota A Kumari BM Shilpa M Vrinda S Umesh C Samuel M Shetty A Tandon P Pandey S Hegde AS Hegde A Balasubramaniam BA Chandramouli V Santosh P Kondaiah K Somasundaram MR Rao, Clin Cancer Res 2008 14 10 2978 2987 10.1158/1078-0432.CCR-07-4821 18483363
26. A network model of a cooperative genetic landscape in brain tumors. M Bredel DM Scholtens GR Harsh C Bredel JP Chandler JJ Renfrow AK Yadav H Vogel AC Scheck R Tibshirani BI Sikic, JAMA 2009 302 3 261 275 10.1001/jama.2009.997 19602686
27. A systems biology-based gene expression classifier of glioblastoma predicts survival with solid tumors. J Zhang B Liu X Jiang H Zhao M Fan Z Fan JJ Lee T Jiang T Jiang SW Song, PLoS One 2009 4 7 6274 10.1371/journal.pone. 0006274 19609451
28. KEGG PATHWAY: Glioma - Homo sapiens (humans). http://www.genome.jp/kegg/ pathway/hsa/hsa05214.html
29. DR Cox D Oakes, Analysis of survival data London: Chapman and Hall 1 1984
30. NCBI-Gene database. http://www.ncbi.nlm.nih.gov/gene
31. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. M Ashburner CA Ball JA Blake D Botstein H Butler JM Cherry AP Davis K Dolinski SS Dwight JT Eppig MA Harris DP Hill L Issel-Tarver A Kasarskis S Lewis JC Matese JE Richardson M Ringwald GM Rubin G Sherlock, Nat Genet 2000 25 1 25 29 10.1038/75556 10802651 (Pubitemid 30257031)
32. KEGG: Kyoto encyclopedia of genes and genomes. M Kanehisa S Goto, Nucleic Acids Res 2000 28 1 27 30 10.1093/nar/28.1.27 10592173 (Pubitemid 30047706)
33. BABELOMICS: a systems biology perspective in the functional annotation of genome-scale experiments. F Al-Shahrour P Minguez J Tarraga D Montaner E Alloza JM Vaquerizas L Conde C Blaschke J Vera J Dopazo, Nucleic Acids Res 2006 34 Web Server issue 472 6 16845052
34. BisoGenet: a new tool for gene network building, visualization and analysis. A Martin ME Ochagavia LC Rabasa J Miranda J Fernandez-de-Cossio R Bringas, BMC Bioinformatics 2010 11 91 10.1186/1471-2105-11-91 20163717
35. Cytoscape: a software environment for integrated models of biomolecular interaction networks. P Shannon A Markiel O Ozier NS Baliga JT Wang D Ramage N Amin B Schwikowski T Ideker, Genome Res 2003 13 11 2498 2504 10.1101/gr.1239303 14597658 (Pubitemid 37428274)
36. Genes involved in radiation therapy response in head and neck cancers. CI Dumur AC Ladd HV Wright LT Penberthy DS Wilkinson CN Powers CT Garrett LJ DiNardo, Laryngoscope 2009 119 1 91 101 10.1002/lary.20005 19117295
37. A hybrid feature selection method for DNA microarray data. LY Chuang CH Yang KC Wu CH Yang, Comput Biol Med 2011 41 4 228 237 10.1016/j.compbiomed.2011. 02.004 21376310
38. Chaotic genetic algorithm for gene selection and classification problems. LY Chuang CS Yang JC Li CH Yang, OMICS 2009 13 5 407 420 10.1089/omi.2009.0007 19594377
39. Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases. U Petrausch P Martus H Tonnies NE Bechrakis D Lenze S Wansel M Hummel N Bornfeld E Thiel MH Foerster U Keilholz, Eye (Lond) 2008 22 8 997 1007
40. Estimation of error rates in discriminant analysis. PA Lachenbruch MR Mickey, Technometrics 1968 10 1 1 11 10.2307/1266219
41. REMBRANDT home page. National Cancer Institute, http://rembrandt.nci.nih. gov
42. Rembrandt: helping personalized medicine become a reality through integrative translational research. S Madhavan JC Zenklusen Y Kotliarov H Sahni HA Fine K Buetow, Mol Cancer Res 2009 7 2 157 167 10.1158/1541-7786.MCR-08-0435 19208739
43. A Computational Strategy To Identify General And Individualized Genomic Biomarkers. KR Delfino SL Rodriguez-Zas NVL Serão BR Southey, Proceedings of the 6th International Symposium on Bioinformatics Research and Applications: 23-26 May 2010; Storrs, Connecticut 2010 31 33
44. Surveillance Epidemiology and End Results. National Cancer Institute, http://seer.cancer.gov/publications/survival
45. Inhibitory effects of adenovirus mediated Akt1 and PIK3R1 shRNA on the growth of malignant tumor cells in vitro and in vivo. Y Fu Q Zhang C Kang J Zhang K Zhang P Pu G Wang T Wang, Cancer Biol Ther 2009 8 11 1002 1009 10.4161/cbt.8.11.8285 19305146
46. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. C Welch Y Chen RL Stallings, Oncogene 2007 26 34 5017 5022 10.1038/sj.onc.1210293 17297439 (Pubitemid 47172643)
47. Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine. S Fre SK Pallavi M Huyghe M Lae KP Janssen S Robine S Artavanis-Tsakonas D Louvard, Proc Natl Acad Sci USA 2009 106 15 6309 6314 10.1073/pnas.0900427106 19251639
48. Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer. ME Mullendore JB Koorstra YM Li GJ Offerhaus X Fan CM Henderson W Matsui CG Eberhart A Maitra G Feldmann, Clin Cancer Res 2009 15 7 2291 2301 10.1158/1078-0432.CCR-08-2004 19258443
49. Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis. S Mittal D Subramanyam D Dey RV Kumar A Rangarajan, Mol Cancer 2009 8 128 10.1186/1476-4598-8-128 20030805
50. Differential expression of a subset of ribosomal protein genes in cell lines derived from human nasopharyngeal epithelium. EU Sim CH Ang CC Ng CW Lee K Narayanan, J Hum Genet 2010 55 2 118 120 10.1038/jhg.2009.124 19927161
51. Colony stimulating factor-1 expression in human glioma. RL Alterman ER Stanley, Mol Chem Neuropathol 1994 21 2-3 177 188 10.1007/BF02815350 8086034 (Pubitemid 24174521)
52. Phospholipase Cgamma1 is required for metastasis development and progression. G Sala F Dituri C Raimondi S Previdi T Maffucci M Mazzoletti C Rossi M Iezzi R Lattanzio M Piantelli S Iacobelli M Broggini M Falasca, Cancer Res 2008 68 24 10187 10196 10.1158/0008-5472.CAN-08-1181 19074886
53. Differentially expressed genes from the glioblastoma cell line SHG-44 treated with all-trans retinoic acid in vitro. Y Zeng Z Yang JG Xu MS Yang ZX Zeng C You, J Clin Neurosci 2009 16 2 285 294 10.1016/j.jocn.2007.11.014 19091570
54. Summary for AKR1C3 (Homo sapiens). Gene Expression Atlas, http://www.ebi.ac.uk/gxa/gene/ENSG00000196139
55. A genetically tractable model of human glioma formation. JN Rich C Guo RE McLendon DD Bigner XF Wang CM Counter, Cancer Res 2001 61 9 3556 3560 11325817 (Pubitemid 32694959)
56. Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. J van den Boom M Wolter R Kuick DE Misek AS Youkilis DS Wechsler C Sommer G Reifenberger SM Hanash, Am J Pathol 2003 163 3 1033 1043 10.1016/S0002-9440(10)63463-3 12937144 (Pubitemid 37040139)
57. Genetic analysis of human glioblastomas using a genomic microarray system. T Suzuki M Maruno K Wada N Kagawa Y Fujimoto N Hashimoto S Izumoto T Yoshimine, Brain Tumor Pathol 2004 21 1 27 34 10.1007/BF02482174 15696966 (Pubitemid 38915180)
58. P53 in Health and Disease. KH Vousden DP Lane, Nat Rev Mol Cell Biol 2007 8 4 275 283 10.1038/nrm2147 17380161 (Pubitemid 46474662)
59. Mining the epigenome for methylated genes in lung cancer. M Tessema SA Belinsky, Proc Am Thorac Soc 2008 5 8 806 810 10.1513/pats.200805-045TH 19017733
60. ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. JA Doherty,, et al. Cancer Epidemiol Biomarkers Prev 2010 19 1 245 250 10.1158/1055-9965.EPI-09-0729 20056644
61. Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis. TA Chan S Glockner JM Yi W Chen L Van Neste L Cope JG Herman V Velculescu KE Schuebel N Ahuja SB Baylin, PLoS Med 2008 5 5 114 10.1371/journal.pmed.0050114 18507500
62. Frequent loss of PDCD4 expression in human glioma: possible role in the tumorigenesis of glioma. F Gao P Zhang C Zhou J Li Q Wang F Zhu C Ma W Sun L Zhang, Oncol Rep 2007 17 1 123 128 17143488
63. Immunoglobulin G expression in carcinomas and cancer cell lines. Z Chen J Gu, FASEB J 2007 21 11 2931 2938 10.1096/fj.07-8073com 17475920 (Pubitemid 47372759)
64. Inflammation and breast cancer. Inflammatory component of mammary carcinogenesis in ErbB2 transgenic mice. RA Calogero F Cordero G Forni F Cavallo, Breast Cancer Res 2007 9 4 211 10.1186/bcr1745 17705881
65. Identification of differentially expressed genes in human lung squamous cell carcinoma using suppression subtractive hybridization. W Sun K Zhang X Zhang W Lei T Xiao J Ma S Guo S Shao H Zhang Y Liu J Yuan Z Hu Y Ma X Feng S Hu J Zhou S Cheng Y Gao, Cancer Lett 2004 212 1 83 93 10.1016/j.canlet.2004.03.023 15246564 (Pubitemid 38887723)
66. Differences in the tumor microenvironment between African-American and European-American breast cancer patients. DN Martin BJ Boersma M Yi M Reimers TM Howe HG Yfantis YC Tsai EH Williams DH Lee RM Stephens AM Weissman S Ambs, PLoS One 2009 4 2 4531 10.1371/journal.pone.0004531 19225562
67. Protein kinase CbetaII regulates its own expression in rat intestinal epithelial cells and the colonic epithelium in vivo. Y Liu W Su EA Thompson M Leitges NR Murray AP Fields, J Biol Chem 2004 279 44 45556 45563 10.1074/jbc.M407701200 15322124 (Pubitemid 39491542)
68. Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B - induced gliomagenesis. M Ferletta L Uhrbom T Olofsson F Ponten B Westermark, Mol Cancer Res 2007 5 9 891 897 10.1158/1541-7786.MCR-07-0113 17855658 (Pubitemid 47416666)
69. Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. JM Nigro A Misra L Zhang I Smirnov H Colman C Griffin N Ozburn M Chen E Pan D Koul WK Yung BG Feuerstein KD Aldape, Cancer Res 2005 65 5 1678 1686 10.1158/0008-5472.CAN-04-2921 15753362 (Pubitemid 40478592)
70. YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma. CE Pelloski A Mahajan M Maor EL Chang S Woo M Gilbert H Colman H Yang A Ledoux H Blair S Passe RB Jenkins KD Aldape, Clin Cancer Res 2005 11 9 3326 3334 10.1158/1078-0432.CCR-04-1765 15867231 (Pubitemid 40627883)
71. A comparative study of protein kinase C activation in gamma-irradiated proliferating and confluent human lung fibroblast cells. R Baskar MP Hande, J Radiat Res (Tokyo) 2009 50 5 415 423 10.1269/jrr.08125
72. Systems biology of human colorectal cancer. RK Nibbe, 2010
73. Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. C Brennan H Momota D Hambardzumyan T Ozawa A Tandon A Pedraza E Holland, PLoS One 2009 4 11 7752 10.1371/journal.pone.0007752 19915670
74. Identification of differentially expressed genes in cutaneous squamous cell carcinoma by microarray expression profiling. I Nindl C Dang T Forschner RJ Kuban T Meyer W Sterry E Stockfleth, Mol Cancer 2006 5 30 10.1186/1476-4598-5- 30 16893473
75. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. CL Nutt DR Mani RA Betensky P Tamayo JG Cairncross C Ladd U Pohl C Hartmann ME McLaughlin TT Batchelor PM Black A von Deimling SL Pomeroy TR Golub DN Louis, Cancer Res 2003 63 7 1602 1607 12670911 (Pubitemid 36373650)
76. Clusterin/apolipoprotein J in human aging and cancer. IP Trougakos ES Gonos, Int J Biochem Cell Biol 2002 34 11 1430 1448 10.1016/S1357-2725(02)00041- 9 12200037 (Pubitemid 35245400)
77. Integrated profiling reveals a global correlation between epigenetic and genetic alterations in mesothelioma. BC Christensen EA Houseman GM Poage JJ Godleski R Bueno DJ Sugarbaker JK Wiencke HH Nelson CJ Marsit KT Kelsey, Cancer Res 2010 70 14 5686 5694 10.1158/0008-5472.CAN-10-0190 20587528
78. Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. L Frederick XY Wang G Eley CD James, Cancer Res 2000 60 5 1383 1387 10728703 (Pubitemid 30152011)
79. Uniform MDM2 overexpression in a panel of glioblastoma multiforme cell lines with divergent EGFR and p53 expression status. ME Halatsch U Schmidt A Unterberg VI Vougioukas, Anticancer Res 2006 26 6B 4191 4194 17201132 (Pubitemid 46031490)
80. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment. E Razis P Selviaridis S Labropoulos JL Norris MJ Zhu DD Song T Kalebic M Torrens A Kalogera-Fountzila G Karkavelas S Karanastasi JA Fletcher G Fountzilas, Clin Cancer Res 2009 15 19 6258 6266 10.1158/1078-0432.CCR-08-1867 19789313
81. The guanine nucleotide exchange factors trio, Ect2, and Vav3 mediate the invasive behavior of glioblastoma. B Salhia NL Tran A Chan A Wolf M Nakada F Rutka M Ennis WS McDonough ME Berens M Symons JT Rutka, Am J Pathol 2008 173 6 1828 1838 10.2353/ajpath.2008.080043 19008376
82. Autocrine TGFalpha expression in the regulation of initiation of human colon carcinoma growth. D Wang W Li W Jiang LE Humphrey GM Howell MG Brattain, J Cell Physiol 1998 177 3 387 395 10.1002/(SICI)1097-4652(199812)177:3<387:: AID-JCP2>3.0.CO;2-L 9808147 (Pubitemid 28524662)
83. The p53-Mdm2 module and the ubiquitin system. D Michael M Oren, Semin Cancer Biol 2003 13 1 49 58 10.1016/S1044-579X(02)00099-8 12507556 (Pubitemid 36269180)
84. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. JD Carpten AL Faber C Horn GP Donoho SL Briggs CM Robbins G Hostetter S Boguslawski TY Moses S Savage M Uhlik A Lin J Du YW Qian DJ Zeckner G Tucker-Kellogg J Touchman K Patel S Mousses M Bittner R Schevitz MH Lai KL Blanchard JE Thomas, Nature 2007 448 7152 439 444 10.1038/nature05933 17611497 (Pubitemid 47123510)
85. Down-regulation of K-ras and H-ras in human brain gliomas. R Lymbouridou G Soufla AM Chatzinikola A Vakis DA Spandidos, Eur J Cancer 2009 45 7 1294 1303 10.1016/j.ejca.2008.12.028 19179066
86. Increased expression of Akt2 and activity of PI3K and cell proliferation with the ascending of tumor grade of human gliomas. G Wang C Kang P Pu, Clin Neurol Neurosurg 2010 112 4 324 327 10.1016/j.clineuro.2010.01.003 20116920
87. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. HS Phillips S Kharbanda R Chen WF Forrest RH Soriano TD Wu A Misra JM Nigro H Colman L Soroceanu PM Williams Z Modrusan BG Feuerstein K Aldape, Cancer Cell 2006 9 3 157 173 10.1016/j.ccr.2006.02.019 16530701 (Pubitemid 43357943)
88. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. RG Verhaak KA Hoadley E Purdom V Wang Y Qi MD Wilkerson CR Miller L Ding T Golub JP Mesirov G Alexe M Lawrence M O'Kelly P Tamayo BA Weir S Gabriel W Winckler S Gupta L Jakkula HS Feiler JG Hodgson CD James JN Sarkaria C Brennan A Kahn PT Spellman RK Wilson TP Speed JW Gray M Meyerson G Getz CM Perou DN Hayes Cancer Genome Atlas Research Network, Cancer Cell 2010 17 1 98 110 10.1016/j.ccr.2009. 12.020 20129251
89. Predicting clinical outcome through molecular profiling in stage III melanoma. T John MA Black TT Toro D Leader CA Gedye ID Davis PJ Guilford JS Cebon, Clin Cancer Res 2008 14 16 5173 5180 10.1158/1078-0432.CCR-07-4170 18698035
90. Progression-associated genes in astrocytoma identified by novel microarray gene expression data reanalysis. TJ MacDonald IF Pollack H Okada S Bhattacharya J Lyons-Weiler, Methods Mol Biol 2007 377 203 222 10.1007/978-1-59745-390-5-13 17634619
91. Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts. JG Hodgson RF Yeh A Ray NJ Wang I Smirnov M Yu S Hariono J Silber HS Feiler JW Gray PT Spellman SR Vandenberg MS Berger CD James, Neuro Oncol 2009 11 5 477 487 10.1215/15228517-2008-113 19139420
92. Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network. M Weller J Felsberg C Hartmann H Berger JP Steinbach J Schramm M Westphal G Schackert M Simon JC Tonn O Heese D Krex G Nikkhah T Pietsch O Wiestler G Reifenberger A von Deimling M Loeffler, J Clin Oncol 2009 27 34 5743 5750 10.1200/JCO.2009.23.0805 19805672
93. Genes with relevance for early to late progression of colon carcinoma based on combined genomic and transcriptomic information from the same patients. KK Lagerstedt E Kristiansson C Lonnroth M Andersson BM Iresjo A Gustafsson E Hansson U Kressner S Nordgren F Enlund K Lundholm, Cancer Inform 2010 9 79 91 20467480
94. Roles for USF-2 in lung cancer proliferation and bronchial carcinogenesis. M Ocejo-Garcia TA Baokbah HL Ashurst D Cowlishaw I Soomro JM Coulson PJ Woll, J Pathol 2005 206 2 151 159 10.1002/path.1775 15856526 (Pubitemid 40754018)
95. Lead exposure, polymorphisms in genes related to oxidative stress, and risk of adult brain tumors. P Bhatti PA Stewart A Hutchinson N Rothman MS Linet PD Inskip P Rajaraman, Cancer Epidemiol Biomarkers Prev 2009 18 6 1841 1848 10.1158/1055-9965.EPI-09-0197 19505917
96. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). J Soulier E Clappier JM Cayuela A Regnault M Garcia-Peydro H Dombret A Baruchel ML Toribio F Sigaux, Blood 2005 106 1 274 286 10.1182/blood-2004-10-3900 15774621 (Pubitemid 40967203)
97. Lin-7C/VELI3/MALS-3: an essential component in metastasis of human squamous cell carcinoma. T Onda K Uzawa D Nakashima K Saito Y Iwadate N Seki T Shibahara H Tanzawa, Cancer Res 2007 67 20 9643 9648 10.1158/0008-5472.CAN-07- 1911 17942893 (Pubitemid 47621210)
98. Associations between gene expressions in breast cancer and patient survival. TK Jenssen WP Kuo T Stokke E Hovig, Hum Genet 2002 111 4-5 411 420 10.1007/s00439-002-0804-5 12384785 (Pubitemid 36075070)
99. Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling". S Pavlides A Tsirigos I Vera N Flomenberg PG Frank MC Casimiro C Wang RG Pestell UE Martinez-Outschoorn A Howell F Sotgia MP Lisanti, Aging (Albany NY) 2010 2 4 185 199
100. Identification of aberrant promoter hypomethylation of HOXA10 in ovarian cancer. W Cheng Y Jiang C Liu O Shen W Tang X Wang, J Cancer Res Clin Oncol 2010 136 8 1221 1227 10.1007/s00432-010-0772-4 20151152
101. Multiple loci identified in a genome-wide association study of prostate cancer. G Thomas KB Jacobs M Yeager P Kraft S Wacholder N Orr K Yu N Chatterjee R Welch A Hutchinson A Crenshaw G Cancel-Tassin BJ Staats Z Wang J Gonzalez-Bosquet J Fang X Deng SI Berndt EE Calle HS Feigelson MJ Thun C Rodriguez D Albanes J Virtamo S Weinstein FR Schumacher E Giovannucci WC Willett O Cussenot A Valeri GL Andriole ED Crawford M Tucker DS Gerhard JF Fraumeni Jr R Hoover RB Hayes DJ Hunter SJ Chanock, Nat Genet 2008 40 3 310 315 10.1038/ng.91 18264096 (Pubitemid 351311773)
102. Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. S Hasegawa Y Furukawa M Li S Satoh T Kato T Watanabe T Katagiri T Tsunoda Y Yamaoka Y Nakamura, Cancer Res 2002 62 23 7012 7017 12460921 (Pubitemid 35424095)
103. A proteomics analysis of cell signaling alterations in colorectal cancer. J Madoz-Gurpide M Canamero L Sanchez J Solano P Alfonso JI Casal, Mol Cell Proteomics 2007 6 12 2150 2164 10.1074/mcp.M700006-MCP200 17848589
104. Prediction of recurrence risk in early breast cancer using human epidermal growth factor 2 and cyclin A2. HP Li JF Ji KY Hou YT Lei HM Zhao J Wang J Zheng JY Liu MP Wang Y Xiao YF Wang YY Lu Y Sun, Chin Med J (Engl) 2010 123 4 431 437
105. HIC gene, a candidate suppressor gene within a minimal region of loss at 7q31.1 in myeloid neoplasms. D Cigognini G Corneo E Fermo A Zanella P Tripputi, Leuk Res 2007 31 4 477 482 10.1016/j.leukres.2006.09.007 17064770 (Pubitemid 46201965)
106. Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles. S Rorive C Maris O Debeir F Sandras M Vidaud I Bieche I Salmon C Decaestecker, J Neuropathol Exp Neurol 2006 65 8 794 807 10.1097/01.jnen.0000228203.12292.a1 16896313 (Pubitemid 44200320)
107. Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men. B Kwabi-Addo S Wang W Chung J Jelinek SR Patierno BD Wang R Andrawis NH Lee V Apprey JP Issa M Ittmann, Clin Cancer Res 2010 16 14 3539 3547 10.1158/1078-0432.CCR-09-3342 20606036
108. Discovery of epigenetically silenced genes by methylated DNA immunoprecipitation in colon cancer cells. FV Jacinto E Ballestar S Ropero M Esteller, Cancer Res 2007 67 24 11481 11486 10.1158/0008-5472.CAN-07-2687 18089774
109. Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas. M Lae EH Ahn GE Mercado S Chuai M Edgar BR Pawel A Olshen FG Barr M Ladanyi, J Pathol 2007 212 2 143 151 10.1002/path.2170 17471488 (Pubitemid 46852092)
110. Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile. K Graham A de las Morenas A Tripathi C King M Kavanah J Mendez M Stone J Slama M Miller G Antoine H Willers P Sebastiani CL Rosenberg, Br J Cancer 2010 102 8 1284 1293 10.1038/sj.bjc.6605576 20197764
111. Gene expression signature and the prediction of ulcerative colitis-associated colorectal cancer by DNA microarray. T Watanabe T Kobunai E Toda T Kanazawa Y Kazama J Tanaka T Tanaka Y Yamamoto K Hata T Kojima T Yokoyama T Konishi Y Okayama Y Sugimoto T Oka S Sasaki Y Ajioka T Muto H Nagawa, Clin Cancer Res 2007 13 2 Pt 1 415 420 17255260 (Pubitemid 46225344)
112. Integrative genomic and gene expression analysis of chromosome 7 identified novel oncogene loci in non-small cell lung cancer. JM Campbell WW Lockwood TP Buys R Chari BP Coe S Lam WL Lam, Genome 2008 51 12 1032 1039 10.1139/G08-086 19088816
113. Pigmentation-related genes and their implication in malignant melanoma susceptibility. LP Fernandez RL Milne G Pita U Floristan E Sendagorta M Feito JA Aviles M Martin-Gonzalez P Lazaro J Benitez G Ribas, Exp Dermatol 2009 18 7 634 642 10.1111/j.1600-0625.2009.00846.x 19320733
114. Integrated genomic and expression profiling in mantle cell lymphoma: identification of gene-dosage regulated candidate genes. M Schraders P Jares S Bea EF Schoenmakers JH van Krieken E Campo PJ Groenen, Br J Haematol 2008 143 2 210 221 10.1111/j.1365-2141.2008.07334.x 18699851
115. Spermatogenesis associated retrogenes are expressed in the human ovary and ovarian cancers. J Rohozinski ML Anderson RE Broaddus CL Edwards CE Bishop, PLoS One 2009 4 3 5064 10.1371/journal.pone.0005064 19333399
116. Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas. M Grade P Hormann S Becker AB Hummon D Wangsa S Varma R Simon T Liersch H Becker MJ Difilippantonio BM Ghadimi T Ried, Cancer Res 2007 67 1 41 56 10.1158/0008-5472.CAN-06-1514 17210682 (Pubitemid 46142758)
117. Differential gene expression profile of retinoblastoma compared to normal retina. A Ganguly CL Shields, Mol Vis 2010 16 1292 1303 20664703
118. Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival. DF Schaeffer DR Owen HJ Lim AK Buczkowski SW Chung CH Scudamore DG Huntsman SS Ng DA Owen, BMC Cancer 2010 10 59 10.1186/1471-2407-10-59 20178612
119. Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma. MW Smith ZN Yue GK Geiss NY Sadovnikova VS Carter L Boix CA Lazaro GB Rosenberg RE Bumgarner N Fausto J Bruix MG Katze, Cancer Res 2003 63 4 859 864 12591738 (Pubitemid 36231988)
120. Gene expression-based molecular diagnostic system for malignant gliomas is superior to histological diagnosis. M Shirahata K Iwao-Koizumi S Saito N Ueno M Oda N Hashimoto JA Takahashi K Kato, Clin Cancer Res 2007 13 24 7341 7356 10.1158/1078-0432.CCR-06-2789 18094416
121. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas. N Ikenaga K Ohuchida K Mizumoto J Yu T Kayashima A Hayashi K Nakata M Tanaka, Hum Pathol 2010
122. Integrative approach for differentially overexpressed genes in gastric cancer by combining large-scale gene expression profiling and network analysis. A Takeno I Takemasa Y Doki M Yamasaki H Miyata S Takiguchi Y Fujiwara K Matsubara M Monden, Br J Cancer 2008 99 8 1307 1315 10.1038/sj.bjc.6604682 18827816
123. Gene expression profiles in gallbladder cancer: the close genetic similarity seen for early and advanced gallbladder cancers may explain the poor prognosis. JH Kim HN Kim KT Lee JK Lee SH Choi SW Paik JC Rhee AW Lowe, Tumour Biol 2008 29 1 41 49 10.1159/000132570 18497548 (Pubitemid 351733219)
124. Gene expression profiling identifies genes predictive of oral squamous cell carcinoma. C Chen E Mendez J Houck W Fan P Lohavanichbutr D Doody B Yueh ND Futran M Upton DG Farwell SM Schwartz LP Zhao, Cancer Epidemiol Biomarkers Prev 2008 17 8 2152 2162 10.1158/1055-9965.EPI-07-2893 18669583
125. DNA amplification and expression of FADD in oral squamous cell carcinoma. C Prapinjumrune K Morita Y Kuribayashi Y Hanabata Q Shi Y Nakajima J Inazawa K Omura, J Oral Pathol Med 2010 39 7 525 532 20040024
126. Bladder cancer stage and outcome by array-based comparative genomic hybridization. E Blaveri JL Brewer R Roydasgupta J Fridlyand S DeVries T Koppie S Pejavar K Mehta P Carroll JP Simko FM Waldman, Clin Cancer Res 2005 11 19 Pt 1 7012 7022 16203795 (Pubitemid 41428761)
127. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications. S Chevillard N Ugolin P Vielh K Ory C Levalois D Elliott GL Clayman AK El-Naggar, Clin Cancer Res 2004 10 19 6586 6597 10.1158/1078-0432.CCR-04-0053 15475448 (Pubitemid 39346555)
128. Expression analysis of thirty one Y chromosome genes in human prostate cancer. YF Lau J Zhang, Mol Carcinog 2000 27 4 308 321 10.1002/(SICI)1098- 2744(200004)27:4<308::AID-MC9>3.0.CO;2-R 10747295 (Pubitemid 30192001)
129. Autoimmunity and lymphoma: is mantle cell lymphoma a mistake of the receptor editing mechanism? R Garcia-Munoz C Panizo M Bendandi L Llorente, Leuk Res 2009 33 11 1437 1439 10.1016/j.leukres.2009.05.008 19523686
130. Histology-based expression profiling yields novel prognostic markers in human glioblastoma. S Dong CL Nutt RA Betensky AO Stemmer-Rachamimov NC Denko KL Ligon DH Rowitch DN Louis, J Neuropathol Exp Neurol 2005 64 11 948 955 10.1097/01.jnen.0000186940.14779.90 16254489 (Pubitemid 41668924)
131. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis. KL Gorringe M Ramakrishna LH Williams A Sridhar SE Boyle JL Bearfoot J Li MS Anglesio IG Campbell, Genes Chromosomes Cancer 2009 48 10 931 942 10.1002/gcc.20694 19603523